1. A class action lawsuit has been filed against TransMedics Group. 2. Allegations include fraud and unsafe business practices by the company. 3. Class members can seek compensation with no upfront costs. 4. The lawsuit covers the period from February 2023 to January 2025. 5. Investors must act by April 15, 2025, to join the case.
The allegations of fraud and unsafe practices could severely harm investor confidence and stock price, similar to past cases where companies faced lawsuits leading to significant price drops, like with Theranos or Enron.
The serious nature of the allegations, coupled with the potential for regulatory scrutiny and compensation claims, indicates a high likelihood of impacting TMDX's stock value significantly.
The immediate effect of the lawsuit will likely drive the stock price down as investors react to the news, potentially leading to volatility in the short term, as seen in cases involving major lawsuits.
Levi & Korsinsky, LLP notifies investors in TransMedics Group, Inc. ("TransMedics" or the "Company") (NASDAQ: TMDX) of a class action securities lawsuit.
The lawsuit seeks to recover losses on behalf of TransMedics investors who were adversely affected by alleged securities fraud between February 28, 2023 and January 10, 2025. Follow the link below to get more information and be contacted by a member of our team:
https://zlk.com/pslra-1/transmedics-group-inc-lawsuit-submission-form-2?prid=133521&wire=4
TMDX investors may also contact Joseph E. Levi, Esq. via email at [email protected] or by telephone at (212) 363-7500.
The filed complaint alleges that defendants made false statements and/or concealed that: (1) TransMedics used kickbacks, fraudulent overbilling, and coercive tactics to generate business and revenue; (2) TransMedics engaged in unsafe practices and hid safety issues and generally lacked safety oversight; (3) the foregoing subjected TransMedics to heightened risk of scrutiny and regulatory risk; and (4) as a result, defendants' statements about its business, operations, and prospects, were materially false and misleading and/or lacked a reasonable basis at all relevant times.
If you suffered a loss in TransMedics during the relevant time frame, you have until April 15, 2025 to request that the Court appoint you as lead plaintiff. Your ability to share in any recovery doesn't require that you serve as a lead plaintiff.
If you are a class member, you may be entitled to compensation without payment of any out-of-pocket costs or fees. There is no cost or obligation to participate.
Over the past 20 years, the team at Levi & Korsinsky has secured hundreds of millions of dollars for aggrieved shareholders and built a track record of winning high-stakes cases. Our firm has extensive expertise representing investors in complex securities litigation and a team of over 70 employees to serve our clients. For seven years in a row, Levi & Korsinsky has ranked in ISS Securities Class Action Services' Top 50 Report as one of the top securities litigation firms in the United States.
Levi & Korsinsky, LLP
Joseph E. Levi, Esq.
Ed Korsinsky, Esq.
33 Whitehall Street, 17th Floor
New York, NY 10004
[email protected]
Tel: (212) 363-7500
Fax: (212) 363-7171
www.zlk.com
SOURCE Levi & Korsinsky, LLP